Pasithea Historical Financial Ratios

KTTAW Stock  USD 0.02  0  8.97%   
Pasithea Therapeutics is promptly reporting on over 75 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Days Sales Outstanding of 0.0 will help investors to properly organize and evaluate Pasithea Therapeutics financial condition quickly.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Pasithea Therapeutics Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

About Pasithea Financial Ratios Analysis

Pasithea TherapeuticsFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Pasithea Therapeutics investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Pasithea financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Pasithea Therapeutics history.

Pasithea Therapeutics Financial Ratios Chart

At this time, Pasithea Therapeutics' Book Value Per Share is fairly stable compared to the past year. Cash Per Share is likely to climb to 17.12 in 2024, whereas Operating Cash Flow Per Share is likely to drop (0.01) in 2024.
Add Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Price Book Value RatioPrice Earnings To Growth Ratio
Days Of Payables OutstandingDividend Payout Ratio
Price To Operating Cash Flows RatioPrice To Free Cash Flows Ratio
Pretax Profit MarginEbt Per Ebit
Operating Profit MarginEffective Tax Rate
Company Equity MultiplierLong Term Debt To Capitalization
Total Debt To CapitalizationReturn On Capital Employed
Debt Equity RatioEbit Per Revenue
Quick RatioDividend Paid And Capex Coverage Ratio
Net Income Per E B TCash Ratio
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On EquityOperating Cycle
Cash Conversion Cycle

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Pasithea Therapeutics stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Pasithea Therapeutics sales, a figure that is much harder to manipulate than other Pasithea Therapeutics Corp multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Ptb Ratio

Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.

Book Value Per Share

The ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements.

Average Payables

The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.

Capex To Depreciation

The ratio of a company's capital expenditures to its depreciation expenses, indicating how much the company is investing in physical assets relative to the aging of existing assets.

Roic

Return on Invested Capital, a profitability ratio that measures the return that an investment generates for those who have provided capital, such as debt holders and equity holders.
Most ratios from Pasithea Therapeutics' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Pasithea Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Pasithea Therapeutics Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
At this time, Pasithea Therapeutics' Book Value Per Share is fairly stable compared to the past year. Cash Per Share is likely to climb to 17.12 in 2024, whereas Operating Cash Flow Per Share is likely to drop (0.01) in 2024.
 2010 2022 2023 (projected)
PB Ratio203.230.380.4
Capex To Depreciation15.5966.065.3E-5

Pasithea Therapeutics fundamentals Correlations

0.83-0.570.990.49-0.93-0.180.83-1.00.980.950.990.74-0.850.74-0.91-0.45-0.621.00.5-0.830.970.710.88-0.88-0.83
0.83-0.920.840.54-0.77-0.151.0-0.830.90.880.870.61-0.710.61-0.75-0.86-0.910.830.42-1.00.80.390.63-0.98-1.0
-0.57-0.92-0.56-0.650.450.32-0.920.57-0.7-0.61-0.61-0.30.37-0.30.580.990.99-0.55-0.480.91-0.50.01-0.270.820.91
0.990.84-0.560.37-0.97-0.030.84-0.990.960.981.00.81-0.920.81-0.86-0.45-0.591.00.36-0.840.990.780.93-0.91-0.84
0.490.54-0.650.37-0.15-0.910.54-0.490.610.280.41-0.130.01-0.13-0.68-0.58-0.760.420.97-0.540.27-0.240.03-0.4-0.54
-0.93-0.770.45-0.97-0.15-0.19-0.770.93-0.88-0.98-0.96-0.910.99-0.910.730.350.45-0.96-0.150.77-0.99-0.88-0.980.870.77
-0.18-0.150.32-0.03-0.91-0.19-0.150.18-0.280.1-0.070.44-0.350.440.440.260.45-0.09-0.940.150.070.470.260.00.15
0.831.0-0.920.840.54-0.77-0.15-0.830.90.880.870.61-0.710.61-0.75-0.86-0.910.830.42-1.00.80.390.63-0.98-1.0
-1.0-0.830.57-0.99-0.490.930.18-0.83-0.98-0.95-0.99-0.740.86-0.740.910.450.62-1.0-0.50.83-0.97-0.71-0.880.880.83
0.980.9-0.70.960.61-0.88-0.280.9-0.980.930.970.67-0.790.67-0.91-0.59-0.750.970.58-0.90.930.580.8-0.91-0.9
0.950.88-0.610.980.28-0.980.10.88-0.950.930.980.85-0.950.85-0.79-0.52-0.610.970.24-0.880.990.780.93-0.95-0.88
0.990.87-0.611.00.41-0.96-0.070.87-0.990.970.980.81-0.910.81-0.86-0.51-0.641.00.4-0.870.990.740.91-0.93-0.88
0.740.61-0.30.81-0.13-0.910.440.61-0.740.670.850.81-0.951.0-0.4-0.25-0.260.8-0.14-0.610.860.880.89-0.74-0.62
-0.85-0.710.37-0.920.010.99-0.35-0.710.86-0.79-0.95-0.91-0.95-0.950.620.290.36-0.90.020.71-0.96-0.92-0.980.830.71
0.740.61-0.30.81-0.13-0.910.440.61-0.740.670.850.811.0-0.95-0.4-0.25-0.260.8-0.14-0.610.860.880.89-0.74-0.62
-0.91-0.750.58-0.86-0.680.730.44-0.750.91-0.91-0.79-0.86-0.40.62-0.40.440.67-0.87-0.70.75-0.81-0.47-0.690.750.76
-0.45-0.860.99-0.45-0.580.350.26-0.860.45-0.59-0.52-0.51-0.250.29-0.250.440.96-0.43-0.380.86-0.390.1-0.160.760.86
-0.62-0.910.99-0.59-0.760.450.45-0.910.62-0.75-0.61-0.64-0.260.36-0.260.670.96-0.59-0.610.91-0.520.02-0.280.810.91
1.00.83-0.551.00.42-0.96-0.090.83-1.00.970.971.00.8-0.90.8-0.87-0.43-0.590.42-0.830.990.760.92-0.89-0.83
0.50.42-0.480.360.97-0.15-0.940.42-0.50.580.240.4-0.140.02-0.14-0.7-0.38-0.610.42-0.420.27-0.170.07-0.3-0.42
-0.83-1.00.91-0.84-0.540.770.15-1.00.83-0.9-0.88-0.87-0.610.71-0.610.750.860.91-0.83-0.42-0.81-0.39-0.640.981.0
0.970.8-0.50.990.27-0.990.070.8-0.970.930.990.990.86-0.960.86-0.81-0.39-0.520.990.27-0.810.840.96-0.89-0.81
0.710.390.010.78-0.24-0.880.470.39-0.710.580.780.740.88-0.920.88-0.470.10.020.76-0.17-0.390.840.95-0.56-0.39
0.880.63-0.270.930.03-0.980.260.63-0.880.80.930.910.89-0.980.89-0.69-0.16-0.280.920.07-0.640.960.95-0.76-0.64
-0.88-0.980.82-0.91-0.40.870.0-0.980.88-0.91-0.95-0.93-0.740.83-0.740.750.760.81-0.89-0.30.98-0.89-0.56-0.760.98
-0.83-1.00.91-0.84-0.540.770.15-1.00.83-0.9-0.88-0.88-0.620.71-0.620.760.860.91-0.83-0.421.0-0.81-0.39-0.640.98
Click cells to compare fundamentals

Pasithea Therapeutics Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Pasithea Stock Analysis

When running Pasithea Therapeutics' price analysis, check to measure Pasithea Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pasithea Therapeutics is operating at the current time. Most of Pasithea Therapeutics' value examination focuses on studying past and present price action to predict the probability of Pasithea Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pasithea Therapeutics' price. Additionally, you may evaluate how the addition of Pasithea Therapeutics to your portfolios can decrease your overall portfolio volatility.